Daily as of 3 Nov 16:00 ET
- Price
- above both $41.91 vs 50 $39.25 / 200 $34.67
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 16 Sep 2025 · projected 28 bars out
TEVA | Teva Pharmaceutical IndustriesNYSEHealthcareCommon stock golden cross and death cross projections, cross tests and history
$41.91
+$1.21 (+2.97%)
Teva Pharmaceutical Industries (TEVA) is a NYSE-listed common stock that Cruxta has tracked for 50/200 crosses since 2018.
The 50 SMA has sat above the 200 on the daily since Sep 2025, with no cross projected inside the 30 bars Cruxta tracks. Price sits above the 50 and the 200 on the daily, the weekly and the 4-hour.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- above both $42.09 vs 50 $33.69 / 200 $19.04
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross week of 11 Mar 2024 · projected 24 bars out
4-hour as of 3 Nov 16:00 ET
- Price
- above both $41.91 vs 50 $40.49 / 200 $36.58
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 6 May 2026 · projected 29 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 6 May 2026 | 🟨Golden | 4-hour | 29 bars out | Not tested |
| 2 Apr 2026 | 💀Death | 4-hour | 29 bars out | 3 bar cross test |
| 16 Sep 2025 | 🟨Golden moderate | daily | 28 bars out | Not tested |
| 2 Jun 2025 | 🟨Golden | 4-hour | 21 bars out | — |
| 24 Mar 2025 | 💀Death steep | daily | 29 bars out | Not tested |
About TEVA
ExchangeNYSE
InstrumentCommon stock
Median $ volume, 60 d$205M
4-hour coverageYes, since Oct 2025
History on recordSince 2018
SectorHealthcare
Cap bandlarge